John Robson

Tangent90 Strengthens Account Management Team

London, United Kingdom – 09 March 2022: Tangent90 Ltd, a leading technology company that enables pharma to overcome the challenges of sharing scientific digital content with healthcare professionals, welcome the appointment of John Robson as Account Director.

John joins Tangent90 Limited from huumun Ltd where, in a Business Development and Account Management role, he supported multiple pharmaceutical clients in the development of digital solutions including web, CLM and e-detailing solutions as part of their wider digital eco-system.

“I am really excited to be joining Tangent90, at a time where we are seeing the true potential and growth of engagement through the distribution of copyright scientific content,” John explained. “I look forward to working with the team in delivering solutions that lead to greater and more meaningful engagement with Healthcare Professionals using their digital channels of choice”, he added.

“We are experiencing a significant period of growth and with that the need to rapidly scale the team to ensure we are able to continue delivering a high-quality service for clients”, explained Jan van den Burg, CEO, Tangent90. “John brings extensive digital experience in the healthcare and life sciences industry which will prove valuable for our customers as well as our internal team”, he added.

>> Download Full Article

Related news


Seeing the Value of Scientific Content

In Pharmaceutical Commerce magazine, Tangent90 CEO Jan van den Burg discusses the value that HCPs place on scientific content and highlights the opportunity that pharma should be taking now.


Need to scale up fast? Ready-made content can help

Veeva recently published an eBook which discusses the best practice approach for supporting emerging pharma to launch and scale content faster. It focuses on how digital communications have allowed field teams to spend more quality time with HCPs. What can pharma’s brand teams do to support the increase needed?

Using next best action to inform your engagement strategy

We have been inundated with discussions about big data. Information that can help inform decision making is an output of nearly every phase in life sciences. The industry, with the increased use of digital channels, has been able to collect more data but is this being used to optimise their HCP engagement strategies?

Scroll to Top

Book A Demo

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.